Theralink Technologies Inc (THER)

[petermic]

On November 1, 2021, Theralink Technologies, Inc. ..... Investors agreed to purchase convertible notes and accompanying warrants for $1,000,000.00.

The Notes have an aggregate face value of $1,000,000 and each Note bears interest at a rate of 8% per annum. The Notes will be funded in two tranches on November 1, 2021 and December 1, 2021. The Notes are convertible into shares of the Company’s common stock at a conversion price equal to $0.00366 per share for any amount of principal and accrued interest remaining outstanding (subject to adjustment as provided therein). The Company may prepay the Notes at any time in an amount equal to 110% of outstanding principal balance and accrued interest.

In connection with each Note, the Investors were issued Warrants to purchase an amount of common stock equal to 20% of the shares of common stock issuable upon conversion of the Notes at an exercise price of $0.00366 per share (subject to adjustment as provided therein) until November 1, 2026. The Warrants are exercisable for cash at any time.